Patents by Inventor KLOX TECHNOLOGIES INC.

KLOX TECHNOLOGIES INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHOTOTHERAPY DEVICES AND METHODS
    Publication number: 20130323683
    Abstract: The present disclosure relates to a phototherapy device that can deliver light to tissues to activate photoactive agents that have been applied to the tissues or that are included within a fiber optic tip member of the device which may be coupled to a light source using a sleeve. The present disclosure also relates to methods of phototherapy using the phototherapy device such as anti-bactericidal treatment, anti-fungal treatment, anti-parasitic treatment, anti-viral treatment.
    Type: Application
    Filed: March 12, 2013
    Publication date: December 5, 2013
    Inventor: KLOX TECHNOLOGIES INC.
  • BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT
    Publication number: 20130281913
    Abstract: The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition. The biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 24, 2013
    Inventor: KLOX Technologies Inc.
  • OXIDATITIVE PHOTOACTIVATED SKIN REJEUVENATION COMPOSITION COMPRISING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN
    Publication number: 20130165845
    Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 19, 2013
    Publication date: June 27, 2013
    Applicant: KLOX TECHNOLOGIES INC.
    Inventor: KLOX TECHNOLOGIES INC.